Advanced Medicine Partners CEO Andrew Knudten’s Editorial Published in Endpoints News

An editorial written by Andrew Knudten, CEO of Advanced Medicine Partners, focused on the importance of fully characterizing a manufacturing process to promote patient safety and advance gene therapies, was published by Endpoints News. Read the full piece here.

If you want to learn more about our company’s deep experience and industry-leading expertise, reach out to us